Other drug-induced secondary parkinsonism

OTHER_DRUGADVERS_SECONDA_PARKINSONI

No definition available.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 G21.1#

1 out of 7 registries used, show all original rules.

259

diagram downward connector

Check minimum number of events None

259

diagram downward connector

Include endpoints None

259

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

253

diagram downward connector
OTHER_DRUGADVERS_SECONDA_PARKINSONI

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF5

Summary Statistics

Key figures

All Female Male
Number of individuals 253 125 128
Unadjusted prevalence (%) 0.06 0.05 0.07
Mean age at first event (years) 60.68 62.76 58.64

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: OTHER_DRUGADVERS_SECONDA_PARKINSONI – Other drug-induced secondary parkinsonism
GWS hits:

Survival analyses between endpoints

Plot

before Other drug-induced secondary parkinsonism
after Other drug-induced secondary parkinsonism

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Other drug-induced secondary parkinsonism

Endpoint not on priority list, no data to show.